BCO vs UTHR · P/E 25, rev $5.01B vs P/E 20, rev $2.88B
Brinks Company (BCO) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the BCO and UTHR stock pages for the full models.
Not investment advice.